![David Happel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Happel
Vorstandsvorsitzender bei
SAGIMET BIOSCIENCES INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
David A. Happel is President, Chief Executive Officer & Director at Sagimet Biosciences, Inc. since 2022.
Former roles include Chief Executive Officer at Chrono Therapeutics, Inc. from 2018 to 2020; President & Chief Executive Officer at Cognoa, Inc. from 2020 to 2022; Director-Global Marketing at Warner-Lambert Co. in 2000; Senior Director-Pulmonary Business Unit at InterMune, Inc. in 2002; Director at Boomer Esiason Foundation; Vice President-Pulmonology at Chiron Corp.
in 2006; Head-Sales at Pfizer Inc.; Vice President-Global Sales & Marketing at Dynavax Technologies Corp.; Chief Commercial Officer & EVP at Aerovance, Inc.; Executive Vice President-Orphan Business Unit at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2018; Principal at Parke, Davis & Co. LLC; and Chief Commercial Officer at Horizon Pharmaceutical LLC from 2014 to 2016.
Education includes an MBA from Indiana State University in 1991 and an undergraduate degree from Indiana University in 1984.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 278’166 ( 0.45% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von David Happel
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Vorstandsvorsitzender | 24.10.2022 |
Ehemalige bekannte Positionen von David Happel
| Unternehmen | Position | Ende |
|---|---|---|
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Vorstandsvorsitzender | 14.11.2022 |
Chrono Therapeutics, Inc.
 Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Produces transdermal drug products | Vorstandsvorsitzender | 01.03.2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.02.2018 |
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 01.10.2016 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von David Happel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Produces transdermal drug products | Commercial Services |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Indiana State University
 Indiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boomer Esiason Foundation
 Boomer Esiason Foundation Miscellaneous Commercial ServicesCommercial Services Operates as an association which helps patients suffering from Cystic Fibrosis | Commercial Services |
Parke, Davis & Co. LLC
 Parke, Davis & Co. LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
